265 related articles for article (PubMed ID: 9545148)
1. Relative bioavailability of ondansetron 8-mg oral tablets versus two extemporaneous 16-mg suppositories: formulation and gender differences.
Jann MW; ZumBrunnen TL; Tenjarla SN; Ward ES; Weidler DJ
Pharmacotherapy; 1998; 18(2):288-94. PubMed ID: 9545148
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of three formulations of ondansetron hydrochloride in healthy volunteers: 24-mg oral tablet, rectal suppository, and i.v. infusion.
VanDenBerg CM; Kazmi Y; Stewart J; Weidler DJ; Tenjarla SN; Ward ES; Jann MW
Am J Health Syst Pharm; 2000 Jun; 57(11):1046-50. PubMed ID: 10876746
[TBL] [Abstract][Full Text] [Related]
5. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
Henney HR; Shah J
Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence study of ondansetron tablet in healthy Thai male volunteers.
Lohitnavy M; Chaijittiprasert K; Polnok S; Lohitnavy O; Taytiwat P
J Med Assoc Thai; 2002 Jul; 85(7):808-13. PubMed ID: 12296413
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic profile and clinical efficacy of a once-daily ondansetron suppository in cyclophosphamide-induced emesis: a double blind comparative study with ondansetron tablets.
de Wit R; Beijnen JH; van Tellingen O; Schellens JH; de Boer-Dennert M; Verweij J
Br J Cancer; 1996 Jul; 74(2):323-6. PubMed ID: 8688345
[TBL] [Abstract][Full Text] [Related]
9. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
10. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects.
Strenkoski-Nix LC; Ermer J; DeCleene S; Cevallos W; Mayer PR
Am J Health Syst Pharm; 2000 Aug; 57(16):1499-505. PubMed ID: 10965395
[TBL] [Abstract][Full Text] [Related]
12. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic evaluation of ethionamide suppositories.
Peloquin CA; James GT; McCarthy E; Goble M
Pharmacotherapy; 1991; 11(5):359-63. PubMed ID: 1745621
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
Galan-Herrera JF; Poo JL; Rosales-Sanchez O; Fuentes-Fuentes E; Cariño L; Burke-Fraga V; Namur S; Parra MG
Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138
[TBL] [Abstract][Full Text] [Related]
15. Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: a single-dose, randomized, open-label, crossover study.
Di Girolamo G; Keller GA; de Los Santos AR; Schere D; Gonzalez CD
Clin Ther; 2008 Nov; 30(11):2015-23. PubMed ID: 19108789
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients.
Hosny EA; Al-Marzouki ZM; Metwally ME; Souaida MY; Alshaik AR
Boll Chim Farm; 2003 Oct; 142(8):361-6. PubMed ID: 15040468
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability assessment of salbutamol sulfate suppositories in human volunteers.
Taha EI; Zaghloul AA; Samy AM; Al-Saidan S; Kassem AA; Khan MA
Int J Pharm; 2004 Jul; 279(1-2):3-7. PubMed ID: 15234788
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.
Hatorp V; Oliver S; Su CA
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):636-41. PubMed ID: 9877000
[TBL] [Abstract][Full Text] [Related]
19. Comparative bioavailability study of clonazepam after oral administration of two tablet formulations.
Chauhan BL; Sane SP; Revankar SN; Rammamurthy L; Doshi B; Bhatt AD; Bhate VR; Kulkarni RD
J Assoc Physicians India; 2000 Oct; 48(10):985-7. PubMed ID: 11200924
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
Wonnemann M; Schug B; Anschütz M; Brendel E; De Nucci G; Blume H
Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
